Q4 2024 Holdings
Filed 2025-02-13 | 35 holdings | $116.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Illumina Inc(ILMN) | COM | 452327109 | $15.9M | 119,196 | 13.6% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $12.7M | 368,665 | 10.8% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $7.4M | 436,378 | 6.3% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $6.2M | 133,040 | 5.3% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $6.2M | 235,000 | 5.3% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $5.2M | 125,330 | 4.4% |
| Merus N V | COM | N5749R100 | $5.0M | 120,038 | 4.3% |
| Geron Corp(GERN) | COM | 374163103 | $4.9M | 1,373,550 | 4.2% |
| Incyte Corp(INCY) | COM | 45337C102 | $4.6M | 67,022 | 4.0% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $4.5M | 664,610 | 3.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $4.2M | 106,680 | 3.6% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $3.9M | 321,746 | 3.3% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $3.8M | 187,090 | 3.2% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $3.7M | 19,997 | 3.2% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $3.6M | 79,650 | 3.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $3.4M | 11,122 | 2.9% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $3.3M | 1,883,179 | 2.8% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $2.7M | 49,120 | 2.4% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $2.1M | 64,200 | 1.8% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.9M | 102,984 | 1.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $1.9M | 13,600 | 1.6% |
| Rubrik Inc.(RBRK) | CL A | 781154109 | $1.6M | 24,338 | 1.4% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.3M | 154,522 | 1.1% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $1.2M | 30,875 | 1.1% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $965.2K | 68,943 | 0.8% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $848.6K | 49,082 | 0.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $842.1K | 19,253 | 0.7% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $834.6K | 463,654 | 0.7% |
| Rani Therapeutics Hldgs Inc(RANI) | COM CL A | 753018100 | $676.2K | 493,584 | 0.6% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $624.4K | 1,166,952 | 0.5% |
| Bolt Projs Hldgs Inc | COM | 09769B107 | $391.4K | 811,952 | 0.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $264.5K | 430 | 0.2% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $114.6K | 37,095 | 0.1% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $70.1K | 41,950 | 0.1% |
| Affimed N V | ORDINARY SHS NEW | N01045207 | $44.3K | 37,247 | 0.0% |